Squarepoint’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20,509
| Closed | -$30K | – | 2717 |
|
|
2022
Q2 | $30K | Buy |
+20,509
| New | +$30K | ﹤0.01% | 2004 |
|
|
2022
Q1 | – | Sell |
-100,416
| Closed | -$251K | – | 3088 |
|
|
2021
Q4 | $251K | Buy |
+100,416
| New | +$251K | ﹤0.01% | 1961 |
|
|
2021
Q1 | – | Sell |
-36,159
| Closed | -$393K | – | 3231 |
|
|
2020
Q4 | $393K | Sell |
36,159
-44,212
| -55% | -$481K | ﹤0.01% | 1674 |
|
|
2020
Q3 | $959K | Buy |
80,371
+8,314
| +12% | +$99.2K | 0.01% | 972 |
|
|
2020
Q2 | $1.16M | Buy |
72,057
+57,348
| +390% | +$921K | 0.02% | 848 |
|
|
2020
Q1 | $228K | Buy |
+14,709
| New | +$228K | 0.01% | 1410 |
|
|
2019
Q2 | – | Sell |
-77,700
| Closed | -$963K | – | 2675 |
|
|
2019
Q1 | $963K | Buy |
77,700
+6,247
| +9% | +$77.4K | 0.01% | 1121 |
|
|
2018
Q4 | $440K | Buy |
71,453
+37,753
| +112% | +$232K | 0.01% | 1307 |
|
|
2018
Q3 | $357K | Buy |
33,700
+15,151
| +82% | +$161K | ﹤0.01% | 1460 |
|
|
2018
Q2 | $251K | Buy |
18,549
+4,497
| +32% | +$60.9K | ﹤0.01% | 1456 |
|
|
2018
Q1 | $249K | Buy |
+14,052
| New | +$249K | ﹤0.01% | 1396 |
|
|
2017
Q4 | – | Sell |
-25,902
| Closed | -$493K | – | 2402 |
|
|
2017
Q3 | $493K | Buy |
25,902
+12,479
| +93% | +$238K | 0.01% | 970 |
|
|
2017
Q2 | $203K | Buy |
+13,423
| New | +$203K | ﹤0.01% | 1294 |
|
|
2016
Q1 | – | Sell |
-10,300
| Closed | -$165K | – | 1529 |
|
|
2015
Q4 | $165K | Buy |
+10,300
| New | +$165K | 0.02% | 1053 |
|